Filing metadata

Accession number
0001562180-21-001242
Form type
Form 3
Filer
Akebia Therapeutics, Inc.
CIK
CIK 1517022
Filed
Feb 18, 2021
Reporting period
Feb 16, 2021
Description
Initial ownership

Explore SEC Filings Hub